These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 29786050)

  • 1. Diagnostic Performance of Intestinal
    Peng BJ; Cao CY; Li W; Zhou YJ; Zhang Y; Nie YQ; Cao YW; Li YY
    Chin Med J (Engl); 2018 Jun; 131(11):1349-1356. PubMed ID: 29786050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta-analysis.
    Zhang X; Zhu X; Cao Y; Fang JY; Hong J; Chen H
    Cancer Med; 2019 Feb; 8(2):480-491. PubMed ID: 30636375
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Hussan H; Clinton SK; Roberts K; Bailey MT
    World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Fusobaterium nucleatum in feces and colorectal mucosa as a risk factor for colorectal cancer: a systematic review and meta-analysis.
    Janati AI; Karp I; Laprise C; Sabri H; Emami E
    Syst Rev; 2020 Dec; 9(1):276. PubMed ID: 33272322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between Fusobacterium nucleatum and cancer colorectal: A systematic review and meta-analysis.
    Villar-Ortega P; Expósito-Ruiz M; Gutiérrez-Soto M; Ruiz-Cabello Jiménez M; Navarro-Marí JM; Gutiérrez-Fernández J
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 May; 40(5):224-234. PubMed ID: 35256335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
    Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
    Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
    Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
    Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Fecal
    Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
    Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.
    Wang N; Fang JY
    Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
    Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
    Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19-9, gender, and age.
    Zhao R; Xia D; Chen Y; Kai Z; Ruan F; Xia C; Gong J; Wu J; Wang X
    Cancer Med; 2023 Jul; 12(13):14636-14645. PubMed ID: 37162269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication Study:
    Repass J;
    Elife; 2018 Mar; 7():. PubMed ID: 29533182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium nucleatum, the communication with colorectal cancer.
    Luo K; Zhang Y; Xv C; Ji J; Lou G; Guo X; Chen M; Zhang Y; Wei H; Guo M; Huang R; Yu S
    Biomed Pharmacother; 2019 Aug; 116():108988. PubMed ID: 31112873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.